Tributyrin plus all‐trans‐retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells

O. Witt,S. Schmejkal,A. Pekrun
DOI: https://doi.org/10.1002/1096-8652(200008)64:4<319::AID-AJH16>3.0.CO;2-D
2000-08-01
Abstract:Fourteen butyrate derivatives and retinoic acid were tested with respect to the hemoglobin F‐inducing activity using the K562 erythroleukemia cell line as a model system. Four novel butyrate derivatives with hemoglobin F‐inducing activity have been identified. Combined treatment with the butyrate derivative tributyrin and retinoic acid in vitro led to a 7‐fold increase of hemoglobin synthesis. Tributyrin and retinoic acid might be promising drugs for clinical trials to treat patients with β‐hemoglobinopathies. Am. J. Hematol. 64:319–321, 2000. © 2000 Wiley‐Liss, Inc.
What problem does this paper attempt to address?